Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictoria Regulatory News (VCP)

Share Price Information for Victoria (VCP)

Share Price is delayed by 15 minutes
Get Live Data
39.95    1.95 (5.13%)
Bid:
38.60
Ask:
39.20
Spread: 0.60 (1.554%)
Market Cap: £46.08m
VCP Live PriceLast checked at - London Stock Exchange

Intraday Victoria Share Chart

Pre Stabilisation Notice - Victoria PLC

23 Feb 2021 17:05

RNS Number : 0991Q
Credit Suisse Securities (Eur) Ltd
23 February 2021
 

 

23rd February 2021

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful

 

Victoria PLC

 

Pre-stabilisation Period Announcement

 

Credit Suisse Securities (Europe) Limited (contact: Mithil Vengurlekar telephone: +44 (0) 20 7888 2560) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/08/03/2016 under the Market Abuse Regulation (EU/596/2014).

 

The securities:

Issuer:

Victoria PLC

Guarantor (if any):

Victoria Midco Holdings Limited, Victoria Carpets Limited, Westex (Carpets) Limited, Abingdon Flooring Limited, Interfloor Limited, View Logistics Limited, Ezi Floor Limited, Hanover Flooring Limited, The Victoria Carpet Company Proprietary Limited, Quest Flooring Pty Ltd, Primary Flooring Pty Ltd, Avalon B.V. and GrassInc. B.V.

Aggregate nominal amount:

To be confirmed

Description:

EUR Senior Secured Notes due 2026

Offer price:

To be confirmed

Other offer terms:

Stabilisation:

Stabilisation Manager(s):

Credit Suisse Securities (Europe) Limited

Stabilisation period expected to start on:

February 23rd 2021

Stabilisation period expected to end no later than:

March 24th 2021

Existence, maximum size and conditions of use of over-allotment facility

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law

Stabilisation trading venue

OTC / TBC

 

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAPPUWUPUPGGMW
Date   Source Headline
1st Jun 20267:00 amRNSCEO transition and divisional management structure
8th May 20267:00 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSSale and Leaseback of Belgian Distribution Centre
23rd Feb 20267:00 amRNSTrading Update
11th Feb 20267:00 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSIssue of Equity and Total Voting Rights
13th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSBoard Changes
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
17th Dec 20257:01 amRNSIssue of Equity and Total Voting Rights
17th Dec 20257:00 amRNSHalf-year Report
1st Dec 20257:00 amRNSNotice of Interim Results
26th Nov 20257:00 amRNS-RNew ceramics production line commissioned
6th Nov 20257:00 amRNSHalf-Year Trading Update
21st Oct 20257:00 amRNSWithdrawal of offer to exchange 2028 secured notes
1st Oct 20257:00 amRNSCEO transition
22nd Sep 20257:01 amRNSSummary of 2028 notes exchange to reduce debt
22nd Sep 20257:00 amRNSExchange Offer for 2028 notes
5th Sep 202512:35 pmRNSResult of AGM
5th Sep 20257:00 amRNSAGM Statement
27th Aug 20257:00 amRNSSuccessful extension of 2026 maturities
21st Aug 20257:00 amRNSExpiration and Results of 90% Consent Solicitation
8th Aug 20257:01 amRNSEarly Tender Results of 90% Consent Solicitation
8th Aug 20257:00 amRNS2026 SSNs vote in favour of extending maturity
4th Aug 20257:00 amRNSExercise of LTIP Share Options
1st Aug 20254:40 pmRNSNotice of AGM
31st Jul 20257:00 amRNSFinal Results of Majority Consent Solicitation
24th Jul 20257:03 amRNSConcurrent Consent Solicitations & Exchange Offer
24th Jul 20257:02 amRNSRefinancing of 2026 Senior Secured Notes
24th Jul 20257:01 amRNSAudited results for the year ended 29 March 2025
24th Jul 20257:00 amRNSVictoria Announces Board Change
30th Jun 20257:00 amRNSNew £130m Super Senior Facility
12th May 20254:30 pmRNSHolding(s) in Company
6th May 20257:00 amRNSFY2025 Trading Update
15th Apr 20253:22 pmRNSBoard Appointment and Grant of Options
4th Apr 20257:00 amRNSExercise of LTIP Share Options
17th Mar 20257:56 amRNSVictoria Announces CFO Transition
17th Mar 20257:00 amRNSVictoria Announces CFO Transition
5th Feb 20257:00 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSHolding(s) in Company
10th Jan 20252:55 pmRNSHolding(s) in Company
8th Jan 202511:55 amRNSHolding(s) in Company
8th Jan 20257:00 amRNSBoard Changes & Q3 Update
7th Jan 20253:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.